Research Article
Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
Figure 1
CVB-D attenuates DOX-induced cardiac contractile dysfunction. (a) Representative mouse short-axis echocardiograms. Cardiac function parameters were indicated by (b) LVEDD and (c) LVESD, (d) ejection fraction, and (e) fractional shortening. versus the control group; versus the DOX group, .
(a) |
(b) |
(c) |
(d) |
(e) |